Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Oct-24 4:07 PM View:  | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 27-Sep-24 | Sale (Planned) | 6,162 | $7.46 | $45,968.50 | (2%) 319.36K to 313.19K | |
| 01-Oct-24 4:07 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 27-Sep-24 | Sale | 245 | $7.51 | $1,839.95 | (< 1%) 391.93K to 391.68K | |
| 01-Oct-24 4:07 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 27-Sep-24 | Sale | 648 | $7.51 | $4,866.48 | (< 1%) 524.08K to 523.43K | |
| 01-Oct-24 4:06 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 27-Sep-24 | Sale | 295 | $7.51 | $2,215.45 | (< 1%) 323.83K to 323.54K | |
| 01-Oct-24 4:07 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 27-Sep-24 | Sale | 295 | $7.51 | $2,215.45 | (< 1%) 319.65K to 319.36K | |
| 31-Jul-24 6:43 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 31-Jul-24 | Sale (Planned) | 13,708 | $8.19 | $112,269.00 | (3%) 405.64K to 391.93K | |
| 31-Jul-24 6:43 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 30-Jul-24 | Sale (Planned) | 15,128 | $8.28 | $125,260.00 | (4%) 420.76K to 405.64K | |
| 31-Jul-24 6:43 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 29-Jul-24 | Sale (Planned) | 12,164 | $8.51 | $103,516.00 | (3%) 432.93K to 420.76K | |
| 31-Jul-24 6:43 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 29-Jul-24 | Sale | 1,702 | $8.85 | $15,062.70 | (< 1%) 330.43K to 328.73K | |
| 31-Jul-24 6:42 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 29-Jul-24 | Sale | 2,698 | $8.85 | $23,877.30 | (< 1%) 526.78K to 524.08K | |
| 31-Jul-24 6:42 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 29-Jul-24 | Sale | 1,638 | $8.85 | $14,496.30 | (< 1%) 325.47K to 323.83K | |
| 31-Jul-24 6:43 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 29-Jul-24 | Sale (Planned) | 9,078 | $8.51 | $77,253.80 | (3%) 328.73K to 319.65K | |
| 31-Jul-24 6:43 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 29-Jul-24 | Sale | 1,359 | $8.85 | $12,027.20 | (< 1%) 434.29K to 432.93K | |
| 29-Jul-24 6:37 PM View: | Patel Sanjiv President and CEO Director | Relay Therapeutics, Inc. (RLAY) | 26-Jul-24 | Planned Option Sale | 36,706 | $9.07 | $332,923.00 | (2%) 2.16M to 2.13M | |
| 29-Jul-24 6:37 PM View: | Patel Sanjiv President and CEO Director | Relay Therapeutics, Inc. (RLAY) | 26-Jul-24 | Option Exercise | 36,706 | $5.04 | $184,998.00 | 2% 2.13M to 2.16M | |
| 29-Jul-24 6:37 PM View: | Patel Sanjiv President and CEO Director | Relay Therapeutics, Inc. (RLAY) | 25-Jul-24 | Option Exercise | 50,000 | $5.04 | $252,000.00 | 2% 2.13M to 2.18M | |
| 29-Jul-24 6:37 PM View: | Patel Sanjiv President and CEO Director | Relay Therapeutics, Inc. (RLAY) | 25-Jul-24 | Planned Option Sale | 50,000 | $9.16 | $458,000.00 | (2%) 2.18M to 2.13M | |
| 01-Jul-24 4:41 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 30-Jun-24 | Grant | 2,108 | $5.54 | $11,678.30 | < 1% 432.18K to 434.29K | |
| 01-Jul-24 4:43 PM View: | Patel Sanjiv President and CEO Director | Relay Therapeutics, Inc. (RLAY) | 30-Jun-24 | Grant | 2,108 | $5.54 | $11,678.30 | < 1% 2.13M to 2.13M | |
| 01-Jul-24 4:41 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 27-Jun-24 | Sale | 295 | $6.26 | $1,846.70 | (< 1%) 339.8K to 339.51K | |
| 01-Jul-24 4:41 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 27-Jun-24 | Sale | 245 | $6.26 | $1,533.70 | (< 1%) 432.43K to 432.18K | |
| 01-Jul-24 4:41 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 27-Jun-24 | Sale (Planned) | 9,078 | $6.24 | $56,646.70 | (3%) 339.51K to 330.43K | |
| 01-Jul-24 4:42 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 27-Jun-24 | Sale | 648 | $6.26 | $4,056.48 | (< 1%) 527.43K to 526.78K | |
| 01-Jul-24 4:38 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 27-Jun-24 | Sale | 295 | $6.26 | $1,846.70 | (< 1%) 325.77K to 325.47K | |
| 12-Jun-24 4:06 PM View: | Rubin Jami Director | Relay Therapeutics, Inc. (RLAY) | 10-Jun-24 | Option Exercise | 42,242 | $5.04 | $212,900.00 | 169% 25.0K to 67.24K | |
| 05-Jun-24 8:01 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 05-Jun-24 | Sale (Planned) | 20,450 | $7.06 | $144,377.00 | (5%) 452.88K to 432.43K | |
| 05-Jun-24 8:01 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 04-Jun-24 | Sale (Planned) | 40,595 | $6.64 | $269,551.00 | (8%) 493.47K to 452.88K | |
| 05-Jun-24 8:01 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 03-Jun-24 | Sale | 19,864 | $6.47 | $128,520.00 | (4%) 513.33K to 493.47K | |
| 29-Apr-24 8:31 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 29-Apr-24 | Sale | 1,695 | $6.38 | $10,814.10 | (< 1%) 341.5K to 339.8K | |
| 29-Apr-24 8:30 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 29-Apr-24 | Sale | 2,686 | $6.38 | $17,136.70 | (< 1%) 530.11K to 527.43K | |
| 29-Apr-24 8:33 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 29-Apr-24 | Sale | 1,623 | $6.38 | $10,354.70 | (< 1%) 327.39K to 325.77K | |
| 29-Apr-24 8:36 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 29-Apr-24 | Sale | 1,345 | $6.38 | $8,581.10 | (< 1%) 514.68K to 513.33K | |
| 29-Mar-24 4:15 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 27-Mar-24 | Sale | 765 | $7.70 | $5,890.50 | (< 1%) 530.88K to 530.11K | |
| 29-Mar-24 4:15 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 27-Mar-24 | Sale | 348 | $7.70 | $2,679.60 | (< 1%) 327.74K to 327.39K | |
| 29-Mar-24 4:15 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 27-Mar-24 | Sale | 298 | $7.70 | $2,294.60 | (< 1%) 514.98K to 514.68K | |
| 29-Mar-24 4:15 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 27-Mar-24 | Sale | 348 | $7.70 | $2,679.60 | (< 1%) 341.85K to 341.5K | |
| 31-Jan-24 4:14 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 29-Jan-24 | Sale | 1,651 | $9.64 | $15,915.60 | (< 1%) 516.63K to 514.98K | |
| 31-Jan-24 4:11 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 29-Jan-24 | Sale | 2,005 | $9.64 | $19,328.20 | (< 1%) 343.85K to 341.85K | |
| 31-Jan-24 4:08 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 29-Jan-24 | Sale | 3,178 | $9.64 | $30,635.90 | (< 1%) 534.06K to 530.88K | |
| 31-Jan-24 4:05 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 29-Jan-24 | Sale | 1,929 | $9.64 | $18,595.60 | (< 1%) 329.67K to 327.74K | |
| 18-Jan-24 4:13 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 16-Jan-24 | Grant | 300,000 | -- | -- | 128% 234.06K to 534.06K | |
| 18-Jan-24 4:10 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 16-Jan-24 | Grant | 200,000 | -- | -- | 154% 129.67K to 329.67K | |
| 18-Jan-24 4:25 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 16-Jan-24 | Grant | 200,000 | -- | -- | 63% 316.63K to 516.63K | |
| 18-Jan-24 4:19 PM View: | Patel Sanjiv President and CEO Director | Relay Therapeutics, Inc. (RLAY) | 16-Jan-24 | Grant | 762,360 | -- | -- | 56% 1.36M to 2.13M | |
| 18-Jan-24 4:16 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 16-Jan-24 | Grant | 200,000 | -- | -- | 139% 143.85K to 343.85K | |
| 29-Dec-23 4:22 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 27-Dec-23 | Sale | 294 | $11.51 | $3,383.94 | (< 1%) 144.15K to 143.85K | |
| 29-Dec-23 4:17 PM View: | Bergstrom Donald A President, R&D | Relay Therapeutics, Inc. (RLAY) | 27-Dec-23 | Sale | 977 | $11.51 | $11,245.30 | (< 1%) 235.03K to 234.06K | |
| 29-Dec-23 4:14 PM View: | Adams Brian Chief Legal Officer | Relay Therapeutics, Inc. (RLAY) | 27-Dec-23 | Sale | 294 | $11.51 | $3,383.94 | (< 1%) 129.96K to 129.67K | |
| 29-Dec-23 4:26 PM View: | Rahmer Peter See remarks | Relay Therapeutics, Inc. (RLAY) | 27-Dec-23 | Sale | 244 | $11.51 | $2,808.44 | (< 1%) 316.87K to 316.63K | |
| 01-Nov-23 4:18 PM View: | Catinazzo Thomas Chief Financial Officer | Relay Therapeutics, Inc. (RLAY) | 30-Oct-23 | Sale | 1,697 | $6.03 | $10,232.90 | (1%) 145.84K to 144.15K |
